Literature DB >> 11474425

Ion channel diseases of the central nervous system.

M Li1, H A Lester.   

Abstract

In the last decade, advances in molecular genetics and cellular electrophysiology have increased our understanding of ion channel function. A number of diseases termed "channelopathies" have been discovered that are caused by ion channel dysfunction. Channelopathies can be caused by autoimmune, iatrogenic, toxic or genetic mechanisms. Mutations in genes encoding ion channel proteins that disrupt channel function are now the most commonly identified cause of channelopathies, perhaps because gene disruption is readily detected by the methods of molecular genetics. Ion channels are abundant in the central nervous system (CNS), but CNS channelopathies are rare; however, they overlap with some important neurological disorders, such as epilepsy, ataxia, migraine, schizophrenia, Alzheimer's disease and other neurodegenerative diseases. It is possible that more CNS channelopathies will be discovered when additional ion channels are characterized and the complex mechanisms of brain function are better understood. At present, increased knowledge of the identity, structure and function of ion channels is facilitating diagnosis and treatment of many channelopathies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474425      PMCID: PMC6741647          DOI: 10.1111/j.1527-3458.2001.tb00196.x

Source DB:  PubMed          Journal:  CNS Drug Rev        ISSN: 1080-563X


  7 in total

Review 1.  Modulating inhibitory ligand-gated ion channels.

Authors:  Michael Cascio
Journal:  AAPS J       Date:  2006-05-26       Impact factor: 4.009

2.  Homology modeling and molecular dynamics simulations of the glycine receptor ligand binding domain.

Authors:  Kirill Speranskiy; Michael Cascio; Maria Kurnikova
Journal:  Proteins       Date:  2007-06-01

3.  Chronic deficit in the expression of voltage-gated potassium channel Kv3.4 subunit in the hippocampus of pilocarpine-treated epileptic rats.

Authors:  Luis F Pacheco Otalora; Frank Skinner; Mauro S Oliveira; Bianca Farrell; Massoud F Arshadmansab; Tarun Pandari; Ileana Garcia; Leslie Robles; Gerardo Rosas; Carlos F Mello; Boris S Ermolinsky; Emilio R Garrido-Sanabria
Journal:  Brain Res       Date:  2010-10-21       Impact factor: 3.252

4.  Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease.

Authors:  Vanda A Lennon; Leonid G Ermilov; Joseph H Szurszewski; Steven Vernino
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 5.  The entangled ER-mitochondrial axis as a potential therapeutic strategy in neurodegeneration: A tangled duo unchained.

Authors:  Amit U Joshi; Opher S Kornfeld; Daria Mochly-Rosen
Journal:  Cell Calcium       Date:  2016-05-07       Impact factor: 6.817

6.  Understanding Cerebellum Granular Layer Network Computations through Mathematical Reconstructions of Evoked Local Field Potentials.

Authors:  Harilal Parasuram; Bipin Nair; Giovanni Naldi; Egidio D'Angelo; Shyam Diwakar
Journal:  Ann Neurosci       Date:  2017-10-26

7.  Idiopathic generalized epilepsy and hypokalemic periodic paralysis in a family of South Indian descent.

Authors:  Muthiah Subramanian; N Senthil; S Sujatha
Journal:  Case Rep Neurol Med       Date:  2015-03-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.